The INSTI® Multiplex HIV-1/2 Syphilis Antibody Test delivers highly accurate results in just 60 seconds with a single sample—the fastest dual HIV/syphilis rapid test available. Now included in the ...

QIAGEN N.V. QGEN recently received Emergency Use Authorization (EUA) from the FDA for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay. Notably, the polymerase chain reaction (PCR) multiplex test will ...

NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test receives Emergency Use Authorization by FDA The 4-plex test utilizes the high-throughput, automated testing capabilities of the NeuMoDx systems, which has ...

GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test that ...

A new blood test called the Tick-Borne Disease Serochip (TBD Serochip) promises to revolutionize the diagnosis of tick-borne disease by offering a single test to identify and distinguish between ...

Examination of patients’ responses to direct-to-consumer genetic susceptibility tests is needed to inform clinical practice. This study examined patients’ recall and interpretation of, and responses ...

VANCOUVER, British Columbia & KNOXVILLE, Tenn.--(BUSINESS WIRE)--Augurex Life Sciences Corp. (“Augurex”) today announced the launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents (ASRs), ...

A single blood test called the TDB serochip helps in identifying the pathogen that is responsible for causing Lyme disease and seven other tick-borne pathogens. A single blood test called the ...

“We are excited to expand our infectious disease portfolio into the respiratory market,” said Colin Denver, SpeeDx CEO. “SpeeDx patented technology enables multiple targets to be easily combined into ...

The fastest rapid dual test for HIV and syphilis is now available in Australia, expanding access to reliable and accessible screening. RICHMOND, British Columbia, March 18, 2025 (GLOBE NEWSWIRE) -- ...